Oncogene-induced senescence as an initial barrier in lymphoma development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Acute induction of oncogenic Ras provokes cellular senescence involving the retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo remains elusive. Recently, Rb-mediated silencing of growth-promoting genes by heterochromatin formation associated with methylation of histone H3 lysine 9 (H3K9me) was identified as a critical feature of cellular senescence, which may depend on the histone methyltransferase Suv39h1. Here we show that Emicro-N-Ras transgenic mice harbouring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T-cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wild-type ('control') animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient, lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [120]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“a series of studies [22][23][24][25][26] identified senescence in several premalignant tumours, both in humans and mice.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
In the citing paper
“| DNA damage | Eμ-Nras G12V ; ectopic Bcl2 | Doxorubicin | Lymphoma regression | 22 | | | |”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Self-citationRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelf-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Self-citationSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citation
Cited by
Items 301–400 of 1,001
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Morphological and Functional Characteristic of Senescent Cancer Cells
Sikora, E., Mosieniak, G., & Alicja Sliwinska, M. (2016) · Current Drug Targets · doi:10.2174/1389450116666151019094724 · Cited by 99
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., et al. (2011) · Genes & Development · doi:10.1101/gad.17620611 · Cited by 99
Self-citationCellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 112
Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging
Boulestreau, J., Maumus, M., Rozier, P., Jørgensen, C., & Noël, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00107 · Cited by 107
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 91
Inhibitors of histone demethylases
Lohse, B., Kristensen, J. L., Kristensen, L. H., Agger, K., Helin, K., Gajhede, M., & Clausen, R. P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.046 · Cited by 110
Senescent tumor cells: an overlooked adversary in the battle against cancer
Park, S. S., Choi, Y. W., Kim, J., Kim, H. S., & Park, T. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00717-5 · Cited by 113
Blocking of p53-Snail Binding, Promoted by Oncogenic K-Ras, Recovers p53 Expression and function
Lee, S.-H., Lee, S.-J., Jung, Y. S., Xu, Y., Kang, H. S., Ha, N., & Park, B.-J. (2009) · Neoplasia · doi:10.1593/neo.81006 · Cited by 110
Self-citationJohung, K., Goodwin, E. C., & DiMaio, D. (2007) · Journal of Virology · doi:10.1128/jvi.02348-06 · Cited by 97
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Li, S. K. M., Smith, D. K., Leung, W. Y., Cheung, A. M. S., Lam, E. W. F., Dimri, G. P., & Yao, K.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709604200 · Cited by 97
Dynamic Regulation of p53 Subnuclear Localization and Senescence by MORC3
Takahashi, K., Yoshida, N., Murakami, N., Kawata, K., Ishizaki, H., Tanaka, M., Miyoshi, J., Zinn, A. R., Shime, H., & Inoue, N. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0747 · Cited by 110
Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.015 · Cited by 94
Cellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 107
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 105
The Histone Code of Senescence
Paluvai, H., Di Giorgio, E., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 93
Control of cellular senescence by CPEB
Groisman, I., Ivshina, M., Marin, V., Kennedy, N. J., Davis, R. J., & Richter, J. D. (2006) · Genes & Development · doi:10.1101/gad.1438906 · Cited by 94
MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway
Sheikh, B. N., Phipson, B., El-Saafin, F., Vanyai, H. K., Downer, N. L., Bird, M., Kueh, A. J., May, R. E., Smyth, G. K., Voss, A. K., et al. (2015) · Oncogene · doi:10.1038/onc.2015.33 · Cited by 98
Cellular senescence and chromatin organisation
Narita, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603636 · Cited by 95
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
Lu, Y., Beezhold, K., Chang, Q., Zhang, Y., Rojanasakul, Y., Zhao, H., Castranova, V., Shi, X., & Chen, F. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8927 · Cited by 103
Spyropoulou, A., Gargalionis, A. N., Dalagiorgou, G., Adamopoulos, C., Papavassiliou, K. A., Lea, R. W., Piperi, C., & Papavassiliou, A. G. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8254-x · Cited by 99
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Zampetidis, C. P., Galanos, P., Angelopoulou, A., Zhu, Y., Polyzou, A., Karamitros, T., Kotsinas, A., Lagopati, N., Mourkioti, I., Mirzazadeh, R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.017 · Cited by 87
The role of senescent T cells in immunopathology
Covre, L. P., De Maeyer, R. P. H., Gomes, D. C. O., & Akbar, A. N. (2020) · Aging Cell · doi:10.1111/acel.13272 · Cited by 93
“This process is primarily thought to prevent cancerous transformation of dividing cells (Braig et al., 2005; Chen et al., 2005), but senescence plays a vital role in developmental biology as well as in wound healing/tissue repair (Demaria et al., 2014; Krizhanovsky et al., 2008; Kurundkar et al.,…”
BackgroundGrowth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Wu, P., Becker, A., & Park, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155436 · Cited by 98
Tu, Z., Aird, K. M., Bitler, B. G., Nicodemus, J. P., Beeharry, N., Xia, B., Yen, T. J., & Zhang, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.010 · Cited by 88
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Self-citationSenescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer
Choi, Y. W., Kim, Y. H., Oh, S. Y., Suh, K. W., Kim, Y., Lee, G., Yoon, J. E., Park, S. S., Lee, Y., Park, Y. J., et al. (2021) · Advanced Science · doi:10.1002/advs.202002497 · Cited by 105
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
Zhang, P., & Zhang, M. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00962-x · Cited by 101
RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
Wang, J., Jacob, N. K., Ladner, K. J., Beg, A., Perko, J. D., Tanner, S. M., Liyanarachchi, S., Fishel, R., & Guttridge, D. C. (2009) · EMBO reports · doi:10.1038/embor.2009.197 · Cited by 89
Regulation of transcription and chromatin structure by pRB: Here, there and everywhere
Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 88
Senescence-Associated MicroRNAs
Munk, R. B., Panda, A. C., Grammatikakis, I., Gorospe, M., & Abdelmohsen, K. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.008 · Cited by 99
Massive reshaping of genome-nuclear lamina interactions during oncogene-induced senescence.
Lenain, C., de Graaf, C. A., Pagie, L., Visser, N. L., de Haas, M., de Vries, S. S., Peric-Hupkes, D., van Steensel, B., & Peeper, D. S. (2017) · Genome Research · doi:10.1101/gr.225763.117 · Cited by 89
“Concomi-tantly, OIS was demonstrated to occur in vivo also in response to a variety of other oncogenic mutations, an inactivated tumor suppressor,andin severaltypesofpremalignantlesionsin humanand different mouse models (Braig et al. 2005; Chen et al. 2005; Col-lado et al. 2005).”
Dikovskaya, D., Cole, J. J., Mason, S. M., Nixon, C., Karim, S. A., McGarry, L., Clark, W., Hewitt, R. N., Sammons, M. A., Zhu, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.055 · Cited by 89
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 103
Chromatin-modifying enzymes as therapeutic targets – Part 1
Keppler, B. R., & Archer, T. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1301 · Cited by 95
Dormant cancer cells: programmed quiescence, senescence, or both?
Truskowski, K., Amend, S. R., & Pienta, K. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10073-z · Cited by 92
p16INK4a as a Second Effector of the Telomere Damage Pathway
Jacobs, J. J. L., & de Lange, T. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2104 · Cited by 87
Bandyopadhyay, D., Curry, J. L., Lin, Q., Richards, H. W., Chen, D., Hornsby, P. J., Timchenko, N. A., & Medrano, E. E. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00308.x · Cited by 82
Tumor suppression by p53: making cells senescent.
Qian, Y., & Chen, X. (2010) · PubMed · doi:10.14670/hh-25.515 · Cited by 85
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., & Sun, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808327200 · Cited by 82
Inhibition of SUV39H1 Methyltransferase Activity by DBC1
Li, Z., Chen, L., Kabra, N., Wang, C., Fang, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900956200 · Cited by 90
Camps, J., Grade, M., Nguyen, Q. T., Hörmann, P., Becker, S., Hummon, A. B., Rodriguez, V., Chandrasekharappa, S. C., Chen, Y., Difilippantonio, M. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2864 · Cited by 84
Oskarsson, T., Essers, M. A. G., Dubois, N., Offner, S., Dubey, C., Roger, C., Metzger, D., Chambon, P., Hummler, E., Beard, P., et al. (2006) · Genes & Development · doi:10.1101/gad.381206 · Cited by 82
Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
Hong, S.-K., Yoon, S., Moelling, C., Arthan, D., & Park, J.-I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012591 · Cited by 83
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
Is cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
Lancini, C., van den Berk, P. C. M., Vissers, J. H. A., Gargiulo, G., Song, J., Hulsman, D., Serresi, M., Tanger, E., Blom, M., Vens, C., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131436 · Cited by 92
Vazquez‐Villaseñor, I., Garwood, C. J., Heath, P. R., Simpson, J. E., Ince, P. G., & Wharton, S. B. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12559 · Cited by 82
Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis
De Blander, H., Morel, A.-P., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 72
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 78
Self-citationKolesnichenko, M., Mikuda, N., Höpken, U. E., Kärgel, E., Uyar, B., Tufan, A. B., Milanovic, M., Sun, W., Krahn, I., Schleich, K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2019104296 · Cited by 81
“The epigenetically controlled cell cycle cessation serves as a cell-autonomous barrier to tumor formation (Braig et al , 2005; Collado et al , 2005; Reimann et al , 2010).”
Self-citationNatural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer
Bian, Y., Wei, J., Zhao, C., & Li, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020684 · Cited by 86
Chromatin Remodeling, DNA Damage Repair and Aging
Liu, B., Yip, R. K. H., & Zhou, Z. (2012) · Current Genomics · doi:10.2174/138920212803251373 · Cited by 91
Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors
Haferkamp, S., Scurr, L. L., Becker, T. M., Frausto, M., Kefford, R. F., & Rizos, H. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.5 · Cited by 93
(2019) · doi:10.1101/2019.12.19.882225 · Cited by 81
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Cell senescence in neuropathology: A focus on neurodegeneration and tumours
Carreno, G., Guiho, R., & Martinez‐Barbera, J. P. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12689 · Cited by 74
Runx1Protects Hematopoietic Stem/Progenitor Cells from Oncogenic Insult
Motoda, L., Osato, M., Yamashita, N., Jacob, B., Chen, L. Q., Yanagida, M., Ida, H., Wee, H., Sun, A. X., Taniuchi, I., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0061 · Cited by 82
Lessons from senescence: Chromatin maintenance in non-proliferating cells
Rai, T. S., & Adams, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.07.014 · Cited by 71
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2014) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 71
Breaking news: high-speed race ends in arrest – how oncogenes induce senescence
Micco, R. D., Fumagalli, M., & di Fagagna, F. D. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.012 · Cited by 94
Nakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79
Unexpected Pieces to the Senescence Puzzle
Cichowski, K. M., & Hahn, W. C. (2008) · Cell · doi:10.1016/j.cell.2008.05.027 · Cited by 86
Bustos, S. O., Antunes, F., Rangel, M. C., & Chammas, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.606436 · Cited by 82
miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells
Neault, M., Mallette, F. A., & Richard, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.068 · Cited by 85
Marino, A., Campanella, C., Barone, R., Bavisotto, C. C., Górska‐Ponikowska, M., Woźniak, M., Carini, F., Cappello, F., D’Anneo, A., Lauricella, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.045 · Cited by 83
Xu, M., Yu, Q., Subrahmanyam, R., Difilippantonio, M. J., Ried, T., & Sen, J. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01360-07 · Cited by 75
Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation
Liu, X., Wang, Y., Zhang, X., Gao, Z., Zhang, S., Shi, P., Zhang, X., Song, L., Hendrickson, H., Zhou, D., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.06.013 · Cited by 77
Yates, K. E., Korbel, G. A., Shtutman, M., Roninson, I. B., & DiMaio, D. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00411.x · Cited by 77
The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?☆
Andersen, J. B., & HASSEL, B. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.10.001 · Cited by 82
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76
Keynote review: Chromatin control and cancer-drug discovery: realizing the promise
Inche, A. G., & Thangue, N. B. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03691-3 · Cited by 90
The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype
Montes, M., Lubas, M., Arendrup, F. S., Mentz, B., Rohatgi, N., Tumas, S., Harder, L. M., Skanderup, A. J., Andersen, J., & Lund, A. H. (2021) · Nature Communications · doi:10.1038/s41467-021-22746-4 · Cited by 77
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
Leikam, C., Hufnagel, A. L., Otto, C., Murphy, D. J., Mühling, B., Kneitz, S., Nanda, I., Schmid, M., Wagner, T. U., Haferkamp, S., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.71 · Cited by 74
Comprehensive assessment of cellular senescence in the tumor microenvironment
Wang, X., Ma, L., Pei, X., Wang, H., Tang, X., Pei, J.-F., Ding, Y.-N., Qu, S., Wei, Z.-Y., Wang, H.-Y., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac118 · Cited by 76
Lamina Associated Domains and Gene Regulation in Development and Cancer
Lochs, S. J. A., Kefalopoulou, S., & Kind, J. (2019) · Cells · doi:10.3390/cells8030271 · Cited by 82
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis
Wang, G., Chan, C., Gao, Y., & Lin, H. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10319 · Cited by 83
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
Kim, Y. Y., Um, J., Yoon, J.-H., Lee, D., Lee, Y. J., Kim, D. H., Park, J., & Yun, J. (2019) · The FASEB Journal · doi:10.1096/fj.201901747rr · Cited by 77
The emerging role of p53 in stem cells
Bonizzi, G., Cicalese, A., Insinga, A., & Pelicci, P. G. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.002 · Cited by 78
p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress
Marusyk, A., Wheeler, L. J., Mathews, C. K., & DeGregori, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01316-06 · Cited by 74
Misawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
Cullin-RING ligases in regulation of autophagy
Cui, D., Xiong, X., & Zhao, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0022-5 · Cited by 77
The thorny path linking cellular senescence to organismal aging
Patil, C. K., Mian, S. I., & Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.08.001 · Cited by 83
SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
López-Cobo, S., Fuentealba, J. R., Gueguen, P., Bonté, P.-E., Tsalkitzi, K., Chacón, I., Glauzy, S., Bohineust, A., Biquand, A., Silva, L., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1350 · Cited by 72
DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model
Van Nguyen, T., Puebla-Osorio, N., Pang, H., Dujka, M. E., & Zhu, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062453 · Cited by 72
“An example of these proteins is the heterochromatin protein 1 (HP1) family member HP1γ, which has been established as a marker for senescence-associated heterochromatin foci (SAHF) (20) in human (21) and murine cells (22).”
BackgroundYAP1‐LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis
He, C., Lv, X., Huang, C., Hua, G., Ma, B., Chen, X., Angeletti, P. C., Dong, J., Zhou, J. R., Wang, Z., et al. (2019) · EMBO Reports · doi:10.15252/embr.201744948 · Cited by 78
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Models of reactive oxygen species in cancer
Lu, W., Ogasawara, M. A., & Huang, P. (2007) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2007.10.005 · Cited by 82
Chen, H., Lee, J. S., Liang, X., Zhang, H., Zhu, T., Zhang, Z., Taylor, M. E., Zahnow, C. A., Feigenbaum, L., Rein, A. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2926 · Cited by 72
Kaneda, A., Fujita, T., Anai, M., Yamamoto, S., Nagae, G., Morikawa, M., Tsuji, S., Oshima, M., Miyazono, K., & Aburatani, H. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002359 · Cited by 72
Metadata
- Authors
- Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Medizinische Hochschule Hannover (DE)
- Research Institute of Molecular Pathology (AT)
- Max Delbrück Center (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 660-665
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2080769506
- Cited by
- 1,220
- References
- 31
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 34 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 57 · 2019: 49 · 2018: 49 · 2017: 44 · 2016: 58 · 2015: 53 · 2014: 51 · 2013: 86 · 2012: 69
- FWCI
- 43.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cellular senescence, lymphoma, oncogenic Ras, SUV39H1, H3K9 methylation, heterochromatin, retinoblastoma pathway, p53, T-cell lymphoma, tumor suppression, epigenetic silencing, histone methyltransferase
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lymphoma, Methylation, Methyltransferases, Mice, Transgenic, Precancerous Conditions, Genes, ras, Repressor Proteins, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Disease Progression, Transgenes, ADP-Ribosylation Factors, Chromosomal Instability, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.